Access our specialized publications to stay up to date with the latest consensus statements and clinical studies in key areas.
Cardiovascular diseases ECV they currently occupy first place in mortality and morbidity worldwide, and their prevalence increases with age.
La Dapagliflozin It is a medication belonging to the gliflozin family, sodium-glucose cotransporter 2 inhibitors, used in the treatment of diabetes mellitus.
Details on the mechanism of action, indications, and safety profile of our upcoming drug.
